JDRF applauds the U.S. Food and Drug Administration (FDA) on its decision to provide clearance for the Bigfoot Unity™ Diabetes Management by Bigfoot Biomedical. This new system fills a critical gap and brings benefits of automation and device interconnectedness to people with diabetes who rely on multiple daily injections to manage their blood sugar levels.  

The Bigfoot Unity™ Diabetes Management system is a win for both the type 1 and type 2 diabetes communities as it broadens the options of treatment to alleviate daily burdens. 

Together with the JDRF T1D Fund, we congratulate the Bigfoot Biomedical team on its relentless and continued work to help better the lives of individuals with diabetes.